On December 19th, IDIVAL’s facilities became the venue for the launch of a Cantabrian network of European project managers, an initiative aimed at enhancing the region’s R&D capabilities at the European level. This event, which brought together 24 institutions, marks the beginning of a collaborative strategy to connect Cantabrian research with Brussels and promote participation […]
Raquel Yotti, PERTE’s commissioner for Vanguard Health, visited Cantabria to learn first-hand about advances in healthcare innovation in the region. During her stay, Yotti toured the facilities of the Marqués de Valdecilla Health Research Institute (IDIVAL), where she was briefed on the progress of the VALDATA project, an initiative that seeks to transform the use […]
The Instituto de Investigación Sanitaria Valdecilla (Idival) will be a key actor in the 1st Conference: Humanising our Health System, organised by the Cantabrian Health Cantabrian Health Service (SCS) on 11 December. This event, conceived as a space for reflection and action, will address the importance of placing people at the centre of the health […]
Cantabria has taken a decisive step towards the future of public healthcare with the Digital Health Plan 2024-2028, presented at the conference ‘Cantabria’s Digital Health Plan: connecting innovation and people’. This meeting, held at the Marqués de Valdecilla University Hospital, brought together healthcare professionals, technology experts and managers to discuss how digitalisation can revolutionise healthcare. […]
Next Thursday, 12 December, the Valdecilla Research Institute (IDIVAL), in collaboration with the Carlos III Health Institute (ISCIII) and the Ministry of Health, will hold the conference ‘Your Health, Our Priority’ at the Marqués de Valdecilla University Hospital (Gómez Durán Hall). This event, which is free of charge and open to the general public with […]
The Psychiatry Service of the Marqués de Valdecilla University Hospital has developed the ‘Centre of Excellence for Difficult-to-treat Depression and Suicide Prevention’ programme, reaffirming its commitment to the comprehensive care of these disorders due to their functional, social and economic impact, as well as the risk they pose to patients’ lives. This programme combines a […]
At the meeting of the Board of Trustees held on 29 October 2024, the Valdecilla Health Research Institute (IDIVAL) approved a new R&D&I Quality Policy, reflecting its commitment to excellence, efficiency and continuous improvement in all its research and innovation processes. This policy not only aims to strengthen support for research professionals and guarantee quality […]
On September 19-20, Paloma Lanza from the Health Economics Research Group and Rosa María Cazalilla, representing the IDIVAL working team led by Dr. David Cantarero and Dr. María Jesús Cabero, attended the progress meeting for the European Health4EUkids project. The Health4EUKids Joint Action began in December 2022 with the goal of transferring the experience of […]
IDIVAL (Marqués de Valdecilla Research Institute) is proud to announce a groundbreaking partnership with Iridia Inc., a leading technology company based in California. This collaboration aims to bring to market an innovative DNA encapsulation technology developed by the esteemed research team led by Dr. Mónica López Fanarraga at IDIVAL. The technology has the potential to […]
Researchers from the Nanomedicine Group (IDIVAL-UC) have been recognised with the ‘V Prevencionar Award’ in the Research category, for their pioneering work in the study and training in Nanoprevention. This award highlights the work started in 2010 by the Nanomedicine Group, when its researchers began to explore applications of nanomaterials in various areas. Throughout their […]
